Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
14.73
+0.17 (1.17%)
Aug 26, 2026, 4:00 PM EDT - Market closed

Corvus Pharmaceuticals Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Mizuho Securities
Mizuho Securities
Buy
Reiterates
$30
BuyReiterates$30+103.67%Aug 11, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Maintains
$27
BuyMaintains$27+83.30%Aug 10, 2026
Oppenheimer
Oppenheimer
Buy
Reiterates
$33
BuyReiterates$33+124.03%Aug 7, 2026
Barclays
Barclays
Buy
Maintains
$28
BuyMaintains$28+90.09%Aug 7, 2026
Goldman Sachs
Goldman Sachs
Buy
Maintains
$40
BuyMaintains$40+171.55%May 15, 2026